CI vs PEN · P/E 2.4, rev $274.90B vs P/E 237, rev $1.19B
Cigna Corp (CI) versus Penumbra Inc (PEN) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Penumbra Inc (PEN) is a medical devices company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported PEN revenue for 2024-12-31 was $1.19B. Net income was $14.0M. Revenue was up 319.6% from 2023-12-31 to 2024-12-31. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
CI currently screens at market cap $71.62B and trailing P/E 2.4. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
Not investment advice. Open the CI and PEN stock pages for the full models.
Not investment advice.